Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Convulsive disorders: status epilepticus.

¹Department of Neurology, University of Virginia School of Medicine, Charlottesville.

Clinical Neuropharmacology

|June 1, 1991

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Cerebrovascular Autoregulation Monitoring in the Management of Adult Severe Traumatic Brain Injury: A Delphi Consensus of Clinicians.

Neurocritical care·2021

Same author

Research priorities in neurocritical care.

Neurocritical care·2011

Same author

Report of a National Conference on Donation after cardiac death.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2006

Same author

Changes in severe accidental tetanus mortality in the ICU during two decades in Brazil.

Intensive care medicine·2002

Same author

Critical care neurology.

American journal of respiratory and critical care medicine·2001

Same author

Propofol and midazolam in the treatment of refractory status epilepticus.

Epilepsia·2001

Same journal

Pre-Existing Peak-Dose Dyskinesia and Light Body Weight as Predictors of Ropinirole Patch Dose Modification in Parkinson Disease: A Multicenter Retrospective Study.

Clinical neuropharmacology·2026

Same journal

A Double-blind, Placebo-controlled Study of Lumateperone in the Treatment of Borderline Personality Disorder.

Clinical neuropharmacology·2026

Same journal

Yesterday Once More: Revisiting Catatonia in an Elderly Stroke Patient.

Clinical neuropharmacology·2026

Same journal

Overlapping Hyperosmolar Therapy in Patients With Elevated and Refractory Intracranial Pressure.

Clinical neuropharmacology·2026

Same journal

Letter to the Editor on Multifocal Myoclonus Associated With Trimethoprim-Sulfamethoxazole: A Case Report.

Clinical neuropharmacology·2026

Same journal

Clozapine Induced Myocarditis and Pericarditis: An Analysis of Two Illustrative Cases.

Clinical neuropharmacology·2026

See all related articles

Status epilepticus (SE) is a severe neurological disorder requiring prompt treatment. This review covers current therapies like benzodiazepines, phenytoin, and barbiturates to stop seizures and prevent brain damage.

Area of Science:

Neurology
Neuroscience
Emergency Medicine

Background:

Status epilepticus (SE) is a critical central nervous system disorder.
SE can lead to significant brain damage due to excitotoxic pathways.
Understanding SE mechanisms highlights the need for rapid intervention.

Purpose of the Study:

To review current therapeutic agents for terminating seizures in SE.
To discuss the use of benzodiazepines, phenytoin, and barbiturates in SE management.
To emphasize the importance of timely SE treatment.

Main Methods:

Literature review of existing studies on SE therapies.
Analysis of pharmacological mechanisms of anti-seizure drugs.
Discussion of clinical applications of current SE treatments.

Related Experiment Videos

Main Results:

Current SE therapy relies on agents that halt seizure activity.
Benzodiazepines, phenytoin, and barbiturates are primary treatments.
The review synthesizes information on their efficacy and use in SE.

Conclusions:

Prompt termination of SE is crucial to prevent neurological damage.
Established medications form the cornerstone of acute SE management.
Further understanding of SE pathophysiology informs treatment strategies.